[PCV79] REAL-WORLD COST-EFFECTIVENESS OF RIVAROXABAN COMPARED WITH VITAMIN K ANTAGONISTS IN THE CONTEXT OF STROKE PREVENTION IN ATRIAL FIBRILLATION IN FRANCE

[PCV79] REAL-WORLD COST-EFFECTIVENESS OF RIVAROXABAN COMPARED WITH VITAMIN K ANTAGONISTS IN THE CONTEXT OF STROKE PREVENTION IN ATRIAL FIBRILLATION IN FRANCE

2018 ISPOR Europe

Bowrin, K. | Briere, J.B. | Millier, A. | Levy, P. | Clay, E. | Toumi, M. | Volume: , Issue: , Pages: ,